| Report ID | 277297 |
| Drug Identification Number | 02538431 |
| Brand name | ACETYLCYSTEINE SOLUTION USP |
| Common or Proper name | ACETYLCYSTEINE SOLUTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETYLCYSTEINE |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL INTRAVENOUS INHALATION |
| Packaging size | 200 MG/ML 30 ML |
| ATC code | R05CB |
| ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2026-02-03 |
| Actual start date | |
| Estimated end date | 2026-05-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-06 |
| Company comments | Product is available and on 100% preventative allocation at McKesson. Contract coverage is available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-03-06 | French | Compare |
| v3 | 2026-03-06 | English | Compare |
| v2 | 2026-02-05 | French | Compare |
| v1 | 2026-02-05 | English | Compare |
Showing 1 to 4 of 4